CV
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
NASDAQ·Healthcare·Biotechnology
$5.26
-7.72%
Mkt Cap $18.70M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$1.17 | -$1.41 | -20.51% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$1.55 | -$1.31 | +15.48% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$1.60 | -$1.87 | -16.88% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$1.64 | -$2.09 | -27.44% | — | — |
| Q1 2025 Mar 13, 2025 | — | $2.13K | — | -$1.71 | -$2.74 | -60.23% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$1.83 | -$2.18 | -19.13% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$19.04 | -$2.25 | +88.18% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$1.05 | -$1.50 | -42.86% | — | — |
| Q1 2024 Mar 11, 2024 | — | $2.77K | — | -$1.35 | -$0.75 | +44.44% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$1.05 | -$1.05 | +0.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | — | -$1.35 | — | — | — |
| Q2 2023 May 10, 2023 | — | — | — | — | -$0.41 | — | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | — | -$6.46 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.09 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.04 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.02 | — | — | — |